6505--Pregabalin Capsules 36E79725R0055
Summary
AI-generated · Aug 24, 2025Procurement seeks a single contractor to supply Pregabalin Capsules to VA facilities (including CMOPs and State Veterans Homes options) and DoD, BOP, IHS, and FHCC, for a 1-year base period plus four 1-year option periods. There are 16 line items covering multiple strengths (25 mg to 300 mg) in unit-of-use 90-count bottles and 500-count bottles, with estimated annual usage provided for each item. Offerors must name the exact label wording and hold a unique NDC tied to the supplier; the contractor’s label with that unique NDC must be the only label on the product, with no other labeling applied.
Packaging and labeling requirements specify unit-of-use bottles with a safety-cap that can be deshelled to a non-safety cap or a convertible cap, minimum bottle size of 120 cc, cylindrical body, circumference at least 5.75, and a label dimension of 5.25 x 2 inches plus space for barcode, expiration date, and lot number. The solicitation will be issued in FAR Part 12 commercial item format and posted electronically (SAM.gov) for download; no paper copies, and all responsible sources may submit.
PRE-SOLICITATION NOTICE: The VA National Acquisition Center intends to issue Request for Proposal (RFP) 36E79725R0055 for an unrestricted procurement for Pregabalin Capsules, for the Department of Veterans Affairs (VA) (inclusive of Consolidated Mail Order Pharmacies (CMOPs) and Option 2 State Veterans Homes (SVH)), Department of Defense (DoD), Bureau of Prisons (BOP), Indian Health Service (IHS), and Federal Health Care Center (FHCC). VA will award one contract to the responsible offeror who will be able to provide an uninterrupted source of supply for the contracted items. The contract period will be for one year plus four pre-priced one-year option periods. The contract items will be distributed through the VA s and DOD s respective Pharmaceutical Prime Vendor Programs. Offerors must state the exact name (name that appears on label) by which the drug will be supplied and have an NDC number that is unique to the offeror. The successful offeror/contractor's label with its unique NDC shall be the only label on the product. Contractors shall not affix their label over another label on the product. All unit of use packaging identified in the Schedule of Supplies, (i.e., 90s,) shall contain a safety-cap capable of having the outer part of the cap deshelled and / or a convertible cap to produce a non-safety cap and a bottle with a minimum required size of 120cc volume. The safety cap must not exceed the diameter of the bottle. The bottle must have a cylindrical body and minimum of 5.75 circumference. The bottle must fit a label with a dimension of 5.25 x 2 . The 0.5 additional space is required to keep the bar code exposed and/or allow for the display of the expiration date and lot number. Solicitation # 36E79725R0055 will be electronically issued in commercial item format in accordance with FAR Part 12 on or about September 15, 2025, with a tentative closing date of October 2, 2025. The NAICS code for this procurement is 325412. Any future amendments and other miscellaneous documents will be available electronically for download at sam.gov. No paper copies of the solicitation will be available, and no telephone requests for paper copies of the solicitation will be accepted. Interested offerors are advised to continuously check Contracting Opportunities at SAM.gov for any changes to this solicitation. All responsible sources may submit an offer that if timely received, will be considered. The point of contact for this procurement is Youlanda Duggar. Questions can be e-mailed to Youlanda.Duggar@va.gov. The estimated annual requirements are as follows: Line Item 1 Pregabalin 25mg, 90 Oral Capsules per Bottle (Unit of Use) Total EST Annual Usage (BT): 38,569 Line Item 2 Pregabalin 25mg, 500 Oral Capsules per Bottle Total EST Annual Usage (BT): 3,425 Line Item 3 Pregabalin 50mg, 90 Oral Capsules per Bottle (Unit of Use) Total EST Annual Usage (BT): 92,954 Line Item 4 Pregabalin 50mg, 500 Oral Capsules per Bottle Total EST Annual Usage (BT): 9,111 Line Item 5 Pregabalin 75mg, 90 Oral Capsules per Bottle (Unit of Use) Total EST Annual Usage (BT): 107,709 Line Item 6 Pregabalin 75mg, 500 Oral Capsules per Bottle Total EST Annual Usage (BT): 16,094 Line Item 7 Pregabalin 100mg, 90 Oral Capsules per Bottle (Unit of Use) Total EST Annual Usage (BT): 111,961 Line Item 8 Pregabalin 100mg, 500 Oral Capsules per Bottle Total EST Annual Usage (BT): 14,108 Line Item 9 Pregabalin 150mg, 90 Oral Capsules per Bottle (Unit of Use) Total EST Annual Usage (BT): 127,606 Line Item 10 Pregabalin 150mg, 500 Oral Capsules per Bottle Total EST Annual Usage (BT): 23,011 Line Item 11 Pregabalin 200mg, 90 Oral Capsules per Bottle (Unit of Use) Total EST Annual Usage (BT): 62,900 Line Item 12 Pregabalin 200mg, 500 Oral Capsules per Bottle Total EST Annual Usage (BT): 8,139 Line Item 13 Pregabalin 225mg, 90 Oral Capsules per Bottle (Unit of Use) Total EST Annual Usage (BT): 8,696 Line Item 14 Pregabalin 225mg, 500 Oral Capsules per Bottle Total EST Annual Usage (BT): 3,871 Line Item 15 Pregabalin 300mg, 90 Oral Capsules per Bottle (Unit of Use) Total EST Annual Usage (BT): 16,153 Line Item 16 Pregabalin 300mg, 500 Oral Capsules per Bottle Total EST Annual Usage (BT): 8,474
From Presolicitation posted on Aug 14, 2025N/A
From Solicitation posted on Sep 15, 2025Amendment to Extend Due Date and Time for Offers This amendment is issued to extend the due date and time for receipt of offers submitted in response to solicitation 36E79725R0055 for Pregabalin Capsules from 10/02/2025 to 10/16/2025 at 2:30PM Central Time. All other solicitation terms and conditions remain unchanged. Offerors shall include a completed and signed copy of the amendment with their proposal.
From Solicitation posted on Sep 30, 2025Notice history
4-
-
Solicitation Posted Sep 15, 2025View changes (4)
- Description: Description was updated
- Notice Type: Presolicitation → Solicitation
- Response Deadline: Oct 02, 2025 → Sep 15, 2025
- Set-Aside: None → None
-
Solicitation Posted Sep 30, 2025View changes (2)
- Description: Description was updated
- Response Deadline: Sep 15, 2025 → Oct 16, 2025
-
Award Notice LATEST Posted Feb 11, 2026
Details
Award Information
Awardees
| Company Name | UEI | CAGE Code | Location |
|---|---|---|---|
| SCIEGEN PHARMACEUTICALS INC | WH8BR7NRXLC5 | 8NLP1 | HAUPPAUGE |
Contacts
Contract Specialist
Phone